Munich - Delayed Quote EUR
Sarepta Therapeutics Inc (AB3A.MU)
31.06
-0.32
(-1.02%)
As of 8:00:31 AM GMT+2. Market Open.
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| AB3A.MU | -- | -- | -- | -- |
| S&P 500 | -- | -- | -- | -- |
Upgrades & Downgrades
| Maintains | Wells Fargo: Overweight to Overweight | 5/8/2025 |
| Maintains | RBC Capital: Sector Perform to Sector Perform | 5/7/2025 |
| Maintains | Goldman Sachs: Buy to Buy | 5/7/2025 |
| Maintains | Guggenheim: Buy to Buy | 5/7/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 5/7/2025 |
| Maintains | Oppenheimer: Outperform to Outperform | 5/7/2025 |
Related Tickers
38I.SG Intellia Therapeutics Inc
7.11
-0.62%
TTI.V Thiogenesis Therapeutics, Corp.
0.7300
0.00%
SNSE Sensei Biotherapeutics, Inc.
0.3352
-3.68%
KRON Kronos Bio, Inc.
0.6965
-1.21%
NERV Minerva Neurosciences, Inc.
1.5524
-2.36%
KZR Kezar Life Sciences, Inc.
4.1150
+1.35%
OKUR OnKure Therapeutics, Inc.
2.1600
+4.84%
IPSC Century Therapeutics, Inc.
0.5565
+7.56%
RAPT RAPT Therapeutics, Inc.
0.7820
-3.33%
IFRX InflaRx N.V.
1.7500
-1.69%